Cargando…

Preclinical anti‐angiogenic and anti‐cancer activities of BAY1143269 in glioblastoma via targeting oncogenic protein expression

Glioblastoma angiogenesis is critical for tumor growth, making it an appealing target for treatment development. BAY1143269 is a novel inhibitor of mitogen‐activated protein kinase interacting serine/threonine‐protein kinase 1 (MKN1) and has potent anti‐cancer activity. We identified BAY1143269 as a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wan, Weifeng, Zhang, Xin, Huang, Changren, Chen, Ligang, Yang, Xiaobo, Bao, Kunyang, Peng, Tangming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260954/ https://www.ncbi.nlm.nih.gov/pubmed/35796398 http://dx.doi.org/10.1002/prp2.981

Ejemplares similares

Anti-angiogenic therapies in the management of glioblastoma
por: Schulte, Jessica D., et al.
Publicado: (2021)

SMIM20: a new biological signal associated with the prognosis of glioblastoma
por: Chen, Kai, et al.
Publicado: (2023)

Revisiting anti-angiogenic therapy for recurrent glioblastoma
por: Peters, Katherine B.
Publicado: (2019)

Anti-inflammatory Effects of Traditional Chinese Medicines on Preclinical in vivo Models of Brain Ischemia-Reperfusion-Injury: Prospects for Neuroprotective Drug Discovery and Therapy
por: Peng, Tangming, et al.
Publicado: (2019)

Interactions Between Anti-Angiogenic Therapy and Immunotherapy in Glioblastoma
por: Jain, Saket, et al.
Publicado: (2022)

Feasibility and Safety of Flow Diversion in the Treatment of Intracranial Aneurysms via Transradial Approach: A Single-Arm Meta-Analysis
por: Liu, Xiang, et al.
Publicado: (2022)

Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme
por: Verhoeff, Joost JC, et al.
Publicado: (2009)

Mechanisms of Tumor Development and Anti-angiogenic Therapy in Glioblastoma Multiforme
por: Onishi, Manabu, et al.
Publicado: (2013)

Proteomic analysis predicts anti-angiogenic resistance in recurred glioblastoma
por: Jeon, Hanwool, et al.
Publicado: (2023)

Exploring the Past, Present, and Future of Anti-Angiogenic Therapy in Glioblastoma
por: Zhang, Ashley B., et al.
Publicado: (2023)

LIM and SH3 protein 1 regulates cell growth and chemosensitivity of human glioblastoma via the PI3K/AKT pathway
por: Zhong, Chuanhong, et al.
Publicado: (2018)

Ischemic stroke associated with COVID-19: a systematic review and meta-analysis
por: Luo, Wenzhang, et al.
Publicado: (2021)

Glioblastoma-Specific Strategies of Vascularization: Implications in Anti-Angiogenic Therapy Resistance
por: Buccarelli, Mariachiara, et al.
Publicado: (2022)

Anti-Angiogenic Treatment in Pseudomyxoma Peritonei—Still a Strong Preclinical Rationale
por: Andersson, Yvonne, et al.
Publicado: (2021)

Anti-angiogenic properties of microRNA-29a in preclinical ocular models
por: Peng, De-Wei, et al.
Publicado: (2022)

Frontiers in Anti-Cancer Drug Discovery: Challenges and Perspectives of Metformin as Anti-Angiogenic Add-On Therapy in Glioblastoma
por: Guarnaccia, Laura, et al.
Publicado: (2021)

Targeted Proteomics to Assess the Response to Anti-Angiogenic Treatment in Human Glioblastoma (GBM)
por: Demeure, Kevin, et al.
Publicado: (2016)

Lack of functional normalisation of tumour vessels following anti-angiogenic therapy in glioblastoma
por: Obad, Nina, et al.
Publicado: (2017)

Vorolanib, a novel tyrosine receptor kinase receptor inhibitor with potent preclinical anti-angiogenic and anti-tumor activity
por: Liang, Chris, et al.
Publicado: (2022)

Therapeutic Approaches of Resveratrol on Endometriosis via Anti-Inflammatory and Anti-Angiogenic Pathways
por: Dull, Ana-Maria, et al.
Publicado: (2019)

Anti-Angiogenic Effect of Triptolide in Rheumatoid Arthritis by Targeting Angiogenic Cascade
por: Kong, Xiangying, et al.
Publicado: (2013)

Preclinical Efficacy of Pro- and Anti-Angiogenic Peptide Hydrogels to Treat Age-Related Macular Degeneration
por: Acevedo-Jake, Amanda, et al.
Publicado: (2021)

ANGI-05 PATHOGENESIS OF RESISTANCE (MIMICRY AND CO-OPTION) TO ANTI-ANGIOGENIC TREATMENT FOR GLIOBLASTOMA
por: Takano, Shingo, et al.
Publicado: (2019)

MR spectroscopic imaging predicts early response to anti-angiogenic therapy in recurrent glioblastoma
por: Talati, Pratik, et al.
Publicado: (2021)

Endoglin (CD105) and proliferation index in recurrent glioblastoma treated with anti-angiogenic therapy
por: Bastos, António G. P., et al.
Publicado: (2022)

Angiogenic signaling pathways and anti-angiogenic therapy for cancer
por: Liu, Zhen-Ling, et al.
Publicado: (2023)

Sales for anti-angiogenic drugs
por: Ribatti, Domenico
Publicado: (2017)

Nephrotoxicity of Anti-Angiogenic Therapies
por: Van Wynsberghe, Margaux, et al.
Publicado: (2021)

Mithramycin Exerts an Anti-Myeloma Effect and Displays Anti-Angiogenic Effects through Up-Regulation of Anti-Angiogenic Factors
por: Otjacques, Eléonore, et al.
Publicado: (2013)

Exploring the origin of the cancer stem cell niche and its role in anti-angiogenic treatment for glioblastoma
por: Akindona, Funto A., et al.
Publicado: (2022)

Metabolic changes and anti-tumor effects of a ketogenic diet combined with anti-angiogenic therapy in a glioblastoma mouse model
por: Maeyama, Masahiro, et al.
Publicado: (2021)

Anti-Angiogenic and Anti-Metastatic Activity of Synthetic Phosphoethanolamine
por: Ferreira, Adilson Kleber, et al.
Publicado: (2013)

The Anti-Angiogenic and Anti-Proliferative Activity of Methyl Hydroxychalcone
por: Sahib, Hayder B
Publicado: (2022)

Pleiotropic Anti-Angiogenic and Anti-Oncogenic Activities of the Novel Mithralog Demycarosyl-3D-ß-D-Digitoxosyl-Mithramycin SK (EC-8042)
por: Fernández-Guizán, Azahara, et al.
Publicado: (2015)

Generation of an anti-angiogenic endothelial progenitor cell line via endostatin gene transfer
por: Ai, Jing, et al.
Publicado: (2018)

Vascular Mimicry: A Novel Neovascularization Mechanism Driving Anti-Angiogenic Therapy (AAT) Resistance in Glioblastoma
por: Angara, Kartik, et al.
Publicado: (2017)

Identification of Novel Transcriptome Signature as a Potential Prognostic Biomarker for Anti-Angiogenic Therapy in Glioblastoma Multiforme
por: Zheng, Shuhua, et al.
Publicado: (2021)

Soluble CD146, a biomarker and a target for preventing resistance to anti-angiogenic therapy in glioblastoma
por: Joshkon, Ahmad, et al.
Publicado: (2022)

Anti-Angiogenic Effect of Asperchalasine A Via Attenuation of VEGF Signaling
por: Park, Jun Yeon, et al.
Publicado: (2019)

Anti-Oxidant, Anti-Inflammatory and Anti-Angiogenic Properties of Resveratrol in Ocular Diseases
por: Lançon, Allan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_cl5viq3qmgre7lvjbnen9irur4